Set to enter hospice care, a patient with idiopathic multicentric Castleman's disease is now in remission after treatment with a medication identified by an AI-guided analysis.

The new data will help researchers train next-generation AI models that are applicable to ethnically and demographically ...

Cancer detection rates were 6·4 per 1,000 screened in the group that underwent mammography with AI use compared to five per 1 ...

Groundbreaking Randomized MASAI Trial Demonstrates Transpara® plays a vital role in improving early detection, leading to ...

Revolutionary AI breast cancer screening trial launches across 30 UK sites, promising to tackle radiologist shortages and speed up diagnosis for 700,000 women.

New technology, which hundred of thousands of women will be invited to help test over the coming months, could improve ...

Nearly 700,000 women across the UK will take part in an NHS Artificial Intelligence (AI) trial designed to detect breast ...

A GROUNDBREAKING study in Sweden has found that AI can enhance breast cancer detection in mammography screening while significantly reducing the workload for radiologists.

Nearly 700,000 women across the country will take part in a world-leading trial to test how cutting-edge AI tools can be used to catch breast cancer cases earlier, the Department of Health and Social ...

On World Cancer Day, the UK Government has announced plans to launch a national trial to cut cancer screening wait times.

New research results now published from Lund University's MASAI trial are even better than the initial findings from last ...

Nearly 700,000 women across the UK will take part in what the state-funded National Health Service (NHS) described as a world-leading trial launched on Tuesday – World Cancer Day – to test how ...